Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oral - PhysicianPharm

  • You have access
    89Zr Labeled Anti-PD-1 Antibody PET Monitors phorbol-12-Myristate-13-Acetate (PMA) induced Modulation of Lymphoma PD-1 Expression.
    Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Young Seok Cho and KYUNG-HAN LEE
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 64;
  • You have access
    Unsupervised background removal by dual-modality PET/CT guidance: application to PSMA imaging of metastases
    Ivan Klyuzhin, Yixi Xu, Sara Harsini, Anthony Ortiz, Carlos Uribe, Juan Lavista Ferres and Arman Rahmim
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 36;
  • You have access
    Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody.
    Margaret Daube-Witherspoon, Michael Farwell, John Sunderland, Varsha Viswanath, Ronald Korn, Ian Wilson and Joel Karp
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 61;
  • You have access
    Progression and toxicity following liver Y90 radioembolization: impact of dose metrics, clinical factors, and biomarkers
    Theresa Devasia, Matthew Cousins, Justin Mikell, Ravi Kaza, Matthew Schipper, Kyle Cuneo and Yuni Dewaraja
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 21;
  • You have access
    Evaluation of CCR2 as a theranostic biomarker for abdominal aortic aneurysm
    Gyu Seong Heo, Sergio Sastriques, Lisa Detering, Deborah Sultan, Hannah Luehmann, Batool Arif, Santiago Elizondo Benedetto, Chieh-Yu Lin, Richard Laforest, Robert Gropler, Sean English and Yongjian Liu
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 133;
  • You have access
    Evaluation of [18F]SynVesT-2 for imaging SV2A in the human brain: kinetics, test-retest reproducibility, and binding specificity
    Zhengxin Cai, Yanjun Wu, Lindsey Drake, Mika Naganawa, Soheila Najafzadeh, Richard Pracitto, Marcel Lindemann, Songye Li, Jim Ropchan, David Labaree, Paul Emery, Mark Dias, Shannan Henry, Nabeel Nabulsi, David Matuskey, Jean-Dominique Gallezot, Ansel Hillmer, Richard Carson and Henry Huang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 44;
  • You have access
    Lipophilic Statins in Subjects with Early Mild Cognitive Impairment: Associations with Conversion to Dementia and Decline in Posterior Cingulate Brain Metabolism in a Long-term Prospective Longitudinal Multi-Center Study
    Prasanna Padmanabham, Stephen Liu and Daniel Silverman
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 102;
  • You have access
    68Gallium DOTATATE and Neuroblastoma Restaging and Response to Therapy Evaluation
    Mehdi Djekidel and Ata Maaz
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 91;
  • You have access
    Scintigraphic assessment of proximal and distal phasic antral contraction synchronicity for evaluation of patients with suspected gastroparesis
    Alan Maurer, Natalie Cole, Simindokht Dadparvar, Danielle Powell, Mathew Mathai, Dariush Shahsavari and Henry Parkman
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 141;
  • You have access
    Radiosynthesis and evaluation of (R)- and (S)-18F-OF-NB1 for imaging the GluN2B subunits of the NMDA receptor in non-human primates
    Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul Emery, Hong Gao, Jim Ropchan, Ahmed Haider, Gilles Tamagnan, Richard Carson, Simon Ametamey and Yiyun Huang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 4;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
SNMMI

© 2025 SNMMI

Powered by HighWire